203 related articles for article (PubMed ID: 17999388)
1. p53 regulates FAK expression in human tumor cells.
Golubovskaya VM; Finch R; Kweh F; Massoll NA; Campbell-Thompson M; Wallace MR; Cance WG
Mol Carcinog; 2008 May; 47(5):373-82. PubMed ID: 17999388
[TBL] [Abstract][Full Text] [Related]
2. p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.
Anaganti S; Fernández-Cuesta L; Langerød A; Hainaut P; Olivier M
Cancer Lett; 2011 Jan; 300(2):215-24. PubMed ID: 21071137
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
Golubovskaya V; Kaur A; Cance W
Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
5. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.
Golubovskaya VM; Finch R; Cance WG
J Biol Chem; 2005 Jul; 280(26):25008-21. PubMed ID: 15855171
[TBL] [Abstract][Full Text] [Related]
6. Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth.
Golubovskaya VM; Ho B; Zheng M; Magis A; Ostrov D; Morrison C; Cance WG
BMC Cancer; 2013 Jul; 13():342. PubMed ID: 23841915
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase and p53 signal transduction pathways in cancer.
Golubovskaya VM; Cance W
Front Biosci (Landmark Ed); 2010 Jun; 15(3):901-12. PubMed ID: 20515733
[TBL] [Abstract][Full Text] [Related]
8. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.
Yan W; Liu G; Scoumanne A; Chen X
Cancer Res; 2008 Aug; 68(16):6789-96. PubMed ID: 18701504
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.
Yu HG; Tong SL; Ding YM; Ding J; Fang XM; Zhang XF; Liu ZJ; Zhou YH; Liu QS; Luo HS; Yu JP
Int J Cancer; 2006 Dec; 119(12):2724-32. PubMed ID: 16998832
[TBL] [Abstract][Full Text] [Related]
10. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
11. FAK and p53 protein interactions.
Golubovskaya VM; Cance WG
Anticancer Agents Med Chem; 2011 Sep; 11(7):617-9. PubMed ID: 21355845
[TBL] [Abstract][Full Text] [Related]
12. Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.
Farkas C; Martins CP; Escobar D; Hepp MI; Castro AF; Evan G; Gutiérrez JL; Warren R; Donner DB; Pincheira R
PLoS One; 2013; 8(9):e73817. PubMed ID: 24040083
[TBL] [Abstract][Full Text] [Related]
13. Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.
Junk DJ; Vrba L; Watts GS; Oshiro MM; Martinez JD; Futscher BW
Neoplasia; 2008 May; 10(5):450-61. PubMed ID: 18472962
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression.
Zhao J; Pestell R; Guan JL
Mol Biol Cell; 2001 Dec; 12(12):4066-77. PubMed ID: 11739801
[TBL] [Abstract][Full Text] [Related]
16. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
[TBL] [Abstract][Full Text] [Related]
18. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
Li B; Lee MY
J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 chaperones wild-type p53 tumor suppressor protein.
Walerych D; Kudla G; Gutkowska M; Wawrzynow B; Muller L; King FW; Helwak A; Boros J; Zylicz A; Zylicz M
J Biol Chem; 2004 Nov; 279(47):48836-45. PubMed ID: 15358769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
